| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033262 |
| Receipt No. | R000037916 |
| Scientific Title | A comparison of Head-Mounted Perimeter 'imo' with Humphrey Field Analyzer |
| Date of disclosure of the study information | 2018/07/04 |
| Last modified on | 2019/08/20 (Ver. 3) |
| Basic information | ||
| Public title | A comparison of Head-Mounted Perimeter 'imo' with Humphrey Field Analyzer | |
| Acronym | A comparison of 'imo' with Humphrey | |
| Scientific Title | A comparison of Head-Mounted Perimeter 'imo' with Humphrey Field Analyzer | |
| Scientific Title:Acronym | A comparison of 'imo' with Humphrey | |
| Region |
|
|
| Condition | ||
| Condition | glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the results of the detecting glaucomatous visual field defects between 'imo' and Humphrey
|
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Agreement with MD values of 'imo' and Humphrey perimeter |
| Key secondary outcomes | Test time for the two perimeters
Fixation of eyes during the test for the two perimeters |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with glaucomatous visual field damage
Test visual field with Humphrey Patients who are willing to participate in the study, and who are able to provide written informed consent Patients able to visit the medical institution at pre-defined visits |
|||
| Key exclusion criteria | MD value of Humphrey < -30dB
Patients who show best corrected decimal visual acuity less than 0.1 |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Okayama Univ. Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 700-8558 | ||||||
| Address | 2-5-1 Shikata-cho, Kita-ku,Okayama-shi,Okayama | ||||||
| TEL | 086-235-7297 | ||||||
| tomokoum@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Okayama Univ. Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 700-8558 | ||||||
| Address | 2-5-1 Shikata-cho, Kita-ku,Okayama-shi,Okayama | ||||||
| TEL | 086-235-7297 | ||||||
| Homepage URL | |||||||
| higo_oka@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Okayama Univ. Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Okayama University |
| Address | 700-8558 2-5-1 Shikata-cho Kita-ku Okayama city |
| Tel | 086-235-6503 |
| mae6605@adm.okayama-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study duration:from 2018/6 to 2021/6
Subjects:All subjects that our hospital visited by glaucoma, and met the selection criteria. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037916 |